This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Department's Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC for the provision of influenza virus vaccines. The contract has a ceiling value of $2,405,037.60 and a period of performance ending on September 30, 2016. The contract was not set aside for any specific business category. GlaxoSmithKline, a pharmaceutical company that provides vaccines and other products to U.S. government agencies, has also been awarded multiple indefinite delivery vehicle (IDV) contracts from agencies like the Department of Veterans Affairs and Centers for Disease Control and Prevention to supply seasonal influenza vaccines, vaccine storage and rotation services, and antiviral medications. Additionally, the company has received a federal grant subaward to support a clinical trial for a drug candidate targeting urinary tract infections.